A systemic review of taxanes and their side effects in metastatic breast cancer

Taxanes-containing chemotherapy constitutes an essential backbone for both early and metastatic breast cancer (mBC). However, the two major taxane drugs—paclitaxel and docetaxel—have distinct safety profiles. In this review, we summarize the safety outcome and management following treatment with bot...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Jiun-I., Chao, Ta-Chung, Liu, Chun-Yu, Huang, Chi-Cheng, Tseng, Ling-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592970/
https://www.ncbi.nlm.nih.gov/pubmed/36303832
http://dx.doi.org/10.3389/fonc.2022.940239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592970/
https://www.ncbi.nlm.nih.gov/pubmed/36303832
http://dx.doi.org/10.3389/fonc.2022.940239

Ejemplares similares